BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
NHS Blood and Transplant are contracting with a partner to supply a fully integrated high throughput testing solution for the detection of hepatitis A virus (HAV) RNA and Parvovirus B19 DNA in partnership with NHSBT. The solution has the ability to test for HBV DNA, HIV-1 RNA, HIV-2 RNA, HCV RNA, HEV RNA as contingency during a business continuity need for NHSBTs . The solution has the relevant UKCA marking to support this ability.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Grifols UK Limited | 01456099 | ~£6,100,000 estimated from lot values | 1 lot Lot 1 | - |
This procurement was divided into 1 lots, each awarded separately. 1 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 Oct 2023 – Oct 2030 | £6,100,000 | 1 single bid — no competition | Grifols UK Limited | active |
Weightings from the notice.
Government spending data: This supplier has received £9,697,018 in 354 payments (over £25k) from Guy's and St Thomas' NHS FT, United Lincolnshire Hospitals NHS Trust, Worcestershire Acute Hospitals NHS Trust, Royal Cornwall Hospitals NHS Trust, Plymouth Hospitals NHS Trust and 6 more public bodies (2022-09-27 to 2026-03-31). View full payment history →
Published by the buyer on this notice. Check the original notice — details change and are not updated here.